11.11.2014 Views

COMUNICAZIONI - Giornale Italiano di Cardiologia

COMUNICAZIONI - Giornale Italiano di Cardiologia

COMUNICAZIONI - Giornale Italiano di Cardiologia

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

G Ital Car<strong>di</strong>ol Vol 8 Suppl 2-5 2007<br />

demonstrated the advantage of early abciximab administration on pre-PCI<br />

patency rate of the infarct related artery (IRA), resulting in improved myocar<strong>di</strong>al<br />

reperfusion and clinical outcome. It is not known whether early abciximab<br />

administration influences myocar<strong>di</strong>al reperfusion and functional recovery in the<br />

subgroup of patients without pre-PCI optimal recanalization of the IRA (TIMI 3).<br />

Methods. Out of the 210 consecutive pts enrolled, 174 (83%) showed pre-PCI<br />

TIMI flow rate 4, pre-hospital delay> 2 hrs, pretreatment<br />

delay >2 hrs, and age classes, were not significant. At 5-year follow-up,<br />

mortality resulted significantly correlated with IRV flow before PCI (log rank<br />

p=0.04).<br />

survival<br />

1,0<br />

0,9<br />

0,8<br />

0,7<br />

0,6<br />

0,5<br />

SURVIVAL ACCORDING TO IVR PATENCY BEFORE PCI<br />

TIMI 3= 87%<br />

TIMI 2= 82%<br />

TIMI 0/1= 67%<br />

0 20 40 60 80<br />

follow up (months)<br />

Conclusions. In a real world population, when organizational characteristics and<br />

time delays significantly <strong>di</strong>ffer from RCT, a timely strategy of thrombolysis<br />

followed by PCI (facilitated or rescue) warrants a better IVR patency compared to<br />

the patients receiving a later pPCI, and this possibly explain the better 5-year<br />

survival.<br />

Infarto miocar<strong>di</strong>co acuto: stratificazione prognostica<br />

C92<br />

ELEVATION OF GAMMA-GLUTAMYLTRANSFERASE LEVELS IN DIABETIC<br />

PATIENTS SUFFERING FROM AN ACUTE MYOCARDIAL INFARCTION: AN<br />

INDEX OF ADVERSE OUTCOME<br />

S. Patanè*, F. Marte*, G. Di Bella**, R. Romeo*** , G. D’Andrea****, R. Giuffrè*,<br />

A. Currò*, R. Parisi*<br />

*Car<strong>di</strong>ologia, Nuovo Presi<strong>di</strong>o Ospedaliero Cutroni Zodda-Barcellona P.D.G.<br />

(ME), AUSL 5 Messina, **Car<strong>di</strong>ologia Policlinico Univ. Messina, ***Car<strong>di</strong>ologia,<br />

Ospedale Giarre AUSL3, Catania, ****Diabetologia, Ospedale Milazzo AUSL 5,<br />

Messina<br />

Aim of the study. The pathophysiological dysfunction of protein kinases C<br />

(PKCs) signaling pathways underlies the molecular basis of several<br />

car<strong>di</strong>ovascular responses. In experimental models in obese <strong>di</strong>abetics animals<br />

significant inhibition of insulin-induced glucose uptake, significant increase of<br />

Reactive oxygen species (ROS),of basal glucose uptake and of activity of delta<br />

PKC have been reported.The hypothesis that increased glucose intake increases<br />

oxidative stress, which in turn promotes the activation of delta PKC and that<br />

ad<strong>di</strong>tional mechanisms may be operating to produce ROS under hyperglycemic<br />

con<strong>di</strong>tions, inclu<strong>di</strong>ng the formation of advanced glycation end products or<br />

activation of oxidases such as NADPH oxidase have been reported too. Gammaglutamyltransferase<br />

(GGT) regulates PKC activity and its physiologic role is to<br />

initiate the hydrolysis of extracellular glutathione (GSH). It has also been reported<br />

GGT iron-dependent LDL oxidation and that the products of the GGT irondependent<br />

reaction may themselves lead to increased free ra<strong>di</strong>cal production.<br />

There is some evidence from recent stu<strong>di</strong>es that GGT is independently<br />

associated with car<strong>di</strong>ovascular mortality. Aim of this study was to investigate if<br />

there were relations among higher GGT levels, ejection fraction and adverse<br />

car<strong>di</strong>ac events in <strong>di</strong>abetic patients with Acute Myocar<strong>di</strong>al Infarction (AMI) and<br />

without renal failure.<br />

Methods. We stu<strong>di</strong>ed, in a retrospective analysis,140 <strong>di</strong>abetic patients with AMI<br />

[94 patients with Non-ST-Segment Elevation Myocar<strong>di</strong>al Infarction (NSTEMI) and<br />

36 patients with ST-Segment Elevation Myocar<strong>di</strong>al Infarction (STEMI)], <strong>di</strong>vided in<br />

two groups accor<strong>di</strong>ng to decrease of GGT (108 patients, named dGGT group) or<br />

elevation of GGT (32 patients, named eGGT group) during hospitalization for<br />

AMI. So we fixed a simple endpoint (Recurrent AMI, Heart Failure, Death) within<br />

ten months from hospitalization and a composite endpoint with at least a single<br />

adverse event.<br />

Results. We found significant correlations as follows:<br />

eGGT group (32pt) dGGT group (108pt) P value<br />

Recurrent AMI 34,375% (11/32pt) 5,555556% (6/108pt)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!